LUNG DISEASES, INTERSTITIAL
Clinical trials for LUNG DISEASES, INTERSTITIAL explained in plain language.
Never miss a new study
Get alerted when new LUNG DISEASES, INTERSTITIAL trials appear
Sign up with your email to follow new studies for LUNG DISEASES, INTERSTITIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kids with rare lung disease get long-term safety check on adult drug
Disease control CompletedThis study looked at the long-term safety of nintedanib in children and teens with fibrosing interstitial lung disease, a condition where lung tissue becomes scarred. All 54 participants took nintedanib capsules twice daily for at least 1.5 to 3 years. The goal was to see how wel…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Real-World safety of ofev monitored in 425 lung disease patients
Disease control CompletedThis study looked at the safety of the drug Ofev in 425 people in Japan with a type of lung disease that gets worse over time (progressive fibrosing interstitial lung disease). The main goal was to track any side effects, especially liver problems. Participants had not taken Ofev…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
New drug shows promise in slowing lung scarring in major trial
Disease control CompletedThis study tested a new medicine, BI 1015550, in over 1,100 adults with progressive fibrosing interstitial lung diseases (PF-ILDs) other than idiopathic pulmonary fibrosis. Participants took either a low or high dose of the drug or a placebo twice daily for at least a year. The m…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
Oxygen not needed? new study tests exercise limits in lung disease
Symptom relief CompletedThis study looked at whether people with chronic lung disease can walk just as far without extra oxygen as they can with it. 40 adults with lung conditions that cause low oxygen during exercise completed a 6-minute walk test both with and without supplemental oxygen. The goal was…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Phase: NA • Sponsor: University of Zurich • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Lung scarring study tracks breathing and cough over one year
Knowledge-focused CompletedThis study followed 158 adults with chronic fibrosing interstitial lung disease (a type of lung scarring) who were starting the drug nintedanib. Researchers wanted to see if changes in lung function (measured by a breathing test called FVC) were linked to changes in cough and sho…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated May 17, 2026 05:32 UTC
-
New screening tool aims to catch lung disease early in arthritis patients
Knowledge-focused CompletedThis study aimed to create a simple screening tool to help doctors decide which rheumatoid arthritis patients should get a CT scan to check for lung disease. Researchers looked at risk factors like age, smoking history, and certain blood tests in over 1300 patients. The goal was …
Matched conditions: LUNG DISEASES, INTERSTITIAL
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC